Question 1

What are the potential benefits of participating in this trial for my anemia?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Mircera compare to other anemia treatments I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Mircera or darbepoetin alfa?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. clinical trial (NCT00327535). Contact the study team or your healthcare provider for specific answers.

What this study is about